Intralesional chloroquine in cutaneous leishmaniasis
Keywords:
Saal-dana, cutaneous leishmaniasis, intralesional chloroquine, single lesionAbstract
Background Cutaneous Leishmaniasis (CL) is endemic in certain areas of Pakistan .Thisstudy was carried out to determine the efficacy of intralesional chloroquine in CL.Patients and methods CL patients with single lesion presenting to Leishmaniasis clinic ofTehsil Headquarter Hospital, Sadda from 1st December, 2003 to 30thMarch, 2004 andsubsequently to outpatient department of Hayatabad Medical Complex, Peshawar, wereincluded in the study. The patients were diagnosed clinically and by laboratory confirmationof parasites in a Giemsa – stained smear prepared from the lesion. All important clinicaldetails were recorded on a specially designed pro forma and patients were registered for thepurpose of treatment and a card was issued to them for subsequent visits and follow up.Twelve atients were treated with intralesional chloroquine thrice weekly for three weeks.Results All patients were declared cured on the basis of clinical and pathological criteria at 7weeks (4 weeks after the completion of therapy). No adverse effects were observed.Conclusion Intralesional chloroquine was found to be safe and cost-effective therapy forsingle lesion of cutaneous leishmaniasis. Intralesional chloroquine was used for the first timein the treatment of CL.References
Mujtaba G, Khalid M. Cutaneous
Leishmaniasis in Multan, Pakistan. Int J
Dermatol 1998; 37: 843-6.
Jaffrany M, Haroon TS. Cutaneous
leishmaniasis in Pakistan. Biomedica
; 8: 39-44.
Rahim F, Jamal S, Raziq F et al. An
outbreak of cutaneous Leishmaniasis in
a village of District Dir, N.W.F.P. J
Postgrad Med Inst 2003; 17: 85-8.
World Health Organization (WHO).
Report of Committee. The
Leishmaniasis: World Health Tech Rep
Ser 701, 1984.
Kubba R, Gindan YA. Leishmaniasis.
Dermatol Clin 1989; 7:331-50.
Kolaczinski J, Brooker S, Reyburn H,
Rowland M. Epidemiology
anthroponotic cutaneous leishmaniasis
in Afghan reefugee camps in northwest
Pakistan. Trans R Soc Trop Med Hyg
; 98: 373-8.
Bari AU, Rahman SB. A therapeutic
update on Cutaneous Leishmaniasis. J
Coll Physicians Surg Pak 2003; 13:
-8.
Bogenzieder T, Lehn N, Landthaler M,
Stolz W. Treatment of Old World
cutaneous leishmaniasis with
Intralesionally injected meglumine
antimonite using a dermojet device.
Dermatology 2003; 206: 269-72.
Hussain AB, Amanullah, Dil AF et al.
The efficacy of intralesional sodium
stibogluconate with glucantime. Pak J
Med Res 2002; 41: 54-7.
Kellum RE . Treatment of Cutaneous
Leishmaniasis with an intralesional
drug (Pentostam). J Am Acad Dermatol
: 15: 620-2.